Introduction to common drug forms of larotrectinib

Larotrectinib, an innovative targeted anti-cancer drug, brings new hope to patients suffering from TRK (neurotrophic receptor kinase) gene fusion malignancies. To ensure that every patient can easily access and take this medicine, larotrectinib is mainly available to patients in two forms:

1.Tablet form: For the convenience of patients and the stability of the drug, larotrectinib is often made into tablets. Tablets are solid tablet preparations made by pressing drugs and appropriate excipients. The dosage is accurate and easy to carry. When patients take it, they only need to take it with water according to the doctor's advice and recommendations in the instructions. In addition, the outer packaging of tablets usually has protective measures such as moisture-proof and light-proof to ensure the long-term storage and effectiveness of the medicine.

2.Oral liquid form: In addition to tablets, larotrectinib is also available in oral liquid form for patients to choose from. This liquid dosage form is particularly useful for patients who have difficulty swallowing or who require flexibility in adjusting their dosage. The advantage of oral liquid is that the amount taken each time can be precisely controlled and it is easier to be absorbed by the body. For children and some special patients, oral solutions may be a more ideal choice.

No matter which dosage form is chosen, patients should strictly follow the doctor's instructions to ensure that the drug can achieve maximum therapeutic effect. At the same time, patients should also pay attention to their physical condition and communicate with their doctor in time if they experience any discomfort or abnormal reactions.

To sum up, in order to meet the needs of different patients, larotrectinib has been launched in two main dosage forms: tablets and oral liquids, which not only facilitates patient use, but also ensures the efficacy and safety of the drug.